Literature DB >> 11716097

In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.

C Wongsrichanalai1, K Lin, L W Pang, M A Faiz, H Noedl, T Wimonwattrawatee, A Laoboonchai, F Kawamoto.   

Abstract

In vitro drug susceptibility profiles were assessed in 75 Plasmodium falciparum isolates from 4 sites in Myanmar. Except at Mawlamyine, the site closest to the Thai border, prevalence and degree of resistance to mefloquine were lower among the Myanmar isolates as compared with those from Thailand. Geometric mean concentration that inhibits 50% (IC50) and 90% (IC90) of Mawlamyine isolates were 51 nM (95% confidence interval [CI], 40-65) and 124 nM (95% CI, 104-149), respectively. At the nearest Thai site, Maesod, known for high-level multidrug resistance, the corresponding values for mefloquine IC50 and IC90 were 92 nM (95% CI, 71-121) and 172 nM (95% CI, 140-211). Mefloquine susceptibility of P. falciparum in Myanmar, except for Mawlamyine, was consistent with clinical-parasitological efficacy in semi-immune people. High sensitivity to artemisinin compounds was observed in this geographical region. The data suggest that highly mefloquine-resistant P. falciparum is concentrated in a part of the Thai-Myanmar border region.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716097     DOI: 10.4269/ajtmh.2001.65.450

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.

Authors:  David J Bacon; Christine Latour; Carmen Lucas; Olga Colina; Pascal Ringwald; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar.

Authors:  Byoung-Kuk Na; Hyeong-Woo Lee; Sung-Ung Moon; Tae-Suk In; Khin Lin; Maung Maung; Gyung-Tae Chung; Jong-Koo Lee; Tong-Soo Kim; Yoon Kong
Journal:  Parasitol Res       Date:  2005-05-28       Impact factor: 2.289

3.  Amplification of pfmdr1, pfcrt, pvmdr1, and K13 propeller polymorphisms associated with Plasmodium falciparum and Plasmodium vivax isolates from the China-Myanmar border.

Authors:  Jun Feng; Daili Zhou; Yingxue Lin; Huihui Xiao; He Yan; Zhigui Xia
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

4.  Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.

Authors:  Henglin Yang; Yaming Yang; Pinfang Yang; Xingliang Li; Baihe Gao; Zhiyong Zhang; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2008-09-06       Impact factor: 3.112

5.  Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping.

Authors:  Shengfa Liu; Jianbing Mu; Hongying Jiang; Xin-zhuan Su
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

6.  Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

Authors:  Amy L Pickard; Chansuda Wongsrichanalai; Anne Purfield; Deborah Kamwendo; Kathryn Emery; Christy Zalewski; Fumihiko Kawamoto; R Scott Miller; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.

Authors:  Piyanuch Preechapornkul; Mallika Imwong; Kesinee Chotivanich; Wirichada Pongtavornpinyo; Arjen M Dondorp; Nicholas P J Day; Nicholas J White; Sasithon Pukrittayakamee
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

8.  Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Grennady Wirjanata; Boni Sebayang; Kim A Piera; Sergio Wittlin; Richard K Haynes; Jörg J Möhrle; Nicholas M Anstey; Enny Kenangalem; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

9.  Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.

Authors:  Tyler Brown; Linda S Smith; Eh Kalu Shwe Oo; Kum Shawng; Thomas J Lee; David Sullivan; Chris Beyrer; Adam K Richards
Journal:  Malar J       Date:  2012-09-19       Impact factor: 2.979

10.  Multidrug-resistant genotypes of Plasmodium falciparum, Myanmar.

Authors:  Zhaoqing Yang; Chaoqun Li; Miao Miao; Zaixing Zhang; Xiaodong Sun; Hao Meng; Jie Li; Qi Fan; Liwang Cui
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.